Professor Andrew John Davies

 Andrew Davies is Professor of Haematological Oncology in the Cancer Sciences Unit in
the Faculty of Medicine, University Hospital Southampton. He completed his
training in Medical Oncology at St Bartholomew’s Hospital in London, and as a
Cancer Research UK clinical fellow he undertook a PhD examining the molecular
mechanisms underlying transformation of follicular lymphoma to more aggressive
histological sub-types. 

Prof. Davies specialises in the treatment of malignant lymphoma. He has a particular
interest in the investigation of monoclonal antibody-containing therapies and
other novel therapeutics applied to lymphoma. His work also focuses on translation
of biomarkers and novel therapies to the clinical arena. He has extensive experience in early phase
trials, including leading several first in man lymphoma studies all the way
through to leading late phase studies. 

He
is Chair of the UK National Cancer Research Institute Lymphoma Research Groups
and past Chair of the High Grade Lymphoma Study Group. He is Director of the Cancer
Research UK/National Institute of Health Southampton Experimental Cancer
Medicine Centre. He is also the Wessex regional lead for cancers in Teenagers
and Young Adults (TYA) and Clinical Lead for the Thames Valley and Wessex TYA
Operational Delivery Network